Greenwich Biosciences is developing a seizure medicine derived from the cannabis plant. Photo courtesy of GW Pharmaceuticals Plc.

Greenwich Biosciences is developing a seizure medicine derived from the cannabis plant. Photo courtesy of GW Pharmaceuticals Plc.

Cannabis has so far been relegated to the supplement and medical marijuana industries, with no FDA-approved drug (derived from the plant) available on the market...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129